Drug Trial Radar · NCT07102901
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
351
Planned (sponsor's estimate)
Start
Sep 5, 2025
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, phase 2, open label study to evaluate safety, tolerability and efficacy of SHR2554 combined with other anti-tumor treatments in patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
Conditions
- Advanced Gastric Cancer
- Metastatic Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
Interventions
SHR2554 TabletsDrug
Oral SHR2554 tablets.
SHR-A1811 InjectionDrug
SHR-A1811 for injection.
SHR-A1904 InjectionDrug
SHR-A1904 for injection.
SHR-1701 InjectionDrug
SHR-1701 injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events (AEs).Time frame: Up to approximately 2 years.
- Incidence and severity of serious adverse events (SAEs).Time frame: Up to approximately 2 years.
- Incidence of Dose Limited Toxicity (DLT).Time frame: Up to Day 21.
- Objective response rate (ORR) by the investigator assessment.Time frame: Up to approximately 1 year.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.